Cell Therapy for Anal Sphincter Incontinence: Where Do We Stand?

Area of Science:

• Regenerative Medicine
• Gastroenterology
• Cell Biology

Background:

• Anal sphincter incontinence significantly impacts quality of life and incurs societal costs.
• Current surgical treatments for incontinence have limited success rates.
• Stem/progenitor cell therapy presents a promising alternative to surgery for anal sphincter incontinence.

Purpose of the Study:

• To review the development of cell therapy for anal sphincter incontinence.
• To critically analyze the challenges and pitfalls in current cell therapy approaches.
• To identify areas for future research and standardization.

Main Methods:

• Review of published literature on cell therapy for anal sphincter incontinence.
• Analysis of animal models used to study incontinence and cell therapy.
• Evaluation of cell preparations and their characterization.
• Assessment of clinical studies involving cell therapy for incontinence.

Main Results:

• Animal models varied, with limitations in replicating clinical scenarios.
• Commonly used cell sources include skeletal muscle, bone marrow, and adipose tissue.
• Cell preparation characterization was often incomplete, with stemness not consistently addressed.
• Clinical evaluations in 83 patients yielded encouraging results, despite knowledge gaps.

Conclusions:

• Cell therapy shows potential for treating anal sphincter incontinence.
• Further standardization of cell preparation, delivery methods, and indications is crucial.
• Understanding sphincter healing and cell mechanisms is necessary for clinical advancement.